The cost of care of the less-than-1000-gram infant

Insights

Aggressive treatment for extremely low birth weight (ELBW) infants is ethically justified, despite high costs and risks. Advances in perinatal medicine enable survival, with many survivors achieving normal or mild handicaps, offering significant societal and economic benefits.

Area of Science:

  • Neonatal Intensive Care
  • Perinatal Medicine
  • Bioethics

Background:

  • The ethical management of extremely low birth weight (ELBW) infants presents significant challenges in neonatal intensive care.
  • Advances in perinatal medicine have improved survival rates for extremely premature infants.

Purpose of the Study:

  • To evaluate the ethical considerations and effectiveness of aggressive medical intervention for ELBW infants.
  • To determine if economic factors should influence treatment decisions for ELBW infants.

Main Methods:

  • Review of current medical literature and survival statistics for ELBW infants.
  • Analysis of the relationship between treatment costs, survival rates, and long-term quality of life.

Main Results:

  • Aggressive treatment improves survival for ELBW infants, with many survivors experiencing normal or mild handicaps.
  • Economic benefits and societal contributions from survivors are measurable, challenging cost-based arguments against intensive care.
  • Neonatal intensive care is crucial for the survival of infants weighing less than 750 gm.

Conclusions:

  • A policy of less aggressive treatment or benign neglect for ELBW infants is not supported by current medical evidence.
  • Aggressive treatment is ethically and medically justifiable for ELBW infants, at least initially.
  • The ethical dilemma of ELBW infant care transcends purely economic considerations.